Embecta Corp. (EMBC)
After hours:
| Previous close | 12.46 |
| Open | 12.48 |
| Bid | 9.11 x 200 |
| Ask | 12.53 x 1800 |
| Day's range | 12.23 - 12.79 |
| 52-week range | 9.93 - 23.75 |
| Volume | |
| Avg. volume | 437,895 |
| Market cap | 720.878M |
| Beta (5Y monthly) | 0.94 |
| PE ratio (TTM) | 10.25 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.60 (4.80%) |
| Ex-dividend date | 28 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes Association’s 84th Scientific Sessions that point to the potential for adults with type 2 diabetes (T2D) to better manage insulin delivery through a patch pump with a larger, 300-unit (u) insulin reservoir, which could provide longer wear times and fewer disposable patches over tim
- GlobeNewswire
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six month periods ended March 31, 2024. "Our performance in the second quarter and fiscal first half of 2024 underscores the resiliency of our base business, as well as strong operational execution by our global team. Since our spinoff approximately two years ago, we've remained steadfast in delivering on
- GlobeNewswire
embecta Announces Quarterly Cash Dividend
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company’s common stock. The dividend is payable on June 14, 2024 to stockholders of record at the close of business on May 28, 2024. About embectaembecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live th
